{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:20:27Z","timestamp":1787948427329,"version":"build-2784847793"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006942","name":"Medical University of South Carolina","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006942","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Community Genet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Early breast cancer risk identification is essential for targeted screening and prevention. Provider uptake of risk-stratified screening remains low, often due to limited education on risk assessment, clinical time restrictions, and limited resources for systematic implementation. Patient perspectives on incorporating screening tools into routine care are not well understood. This study elicited patient experiences and preferences regarding risk assessment and genetic testing in primary care. Twenty semi-structured interviews were conducted with individuals at average and high breast cancer risk. The interview guide was developed using the informed decision-making framework. Participants reviewed a decision aid and provided feedback on risk and genetic testing communication. Interviews were transcribed and thematic analysis was conducted by two independent coders. Study participants had an average age of 44 with 45% of individuals self-reporting high-risk for breast cancer. Women across risk levels desired clear, empathetic communication with detailed screening and genetic testing information. Financial constraints, fear of results, and confidentiality were perceived barriers. Key benefits included informed decision-making and prevention potential. Participants emphasized accessible information, personalized communication, and clear follow-up plans. High-risk participants demonstrated more active information-seeking, desired ongoing support after testing, and emphasized family. Most found the communication guide and decision aid supportive for informed decision-making. Patient-centered communication and accessible, comprehensive information are key for communication of breast cancer risk. Addressing financial barriers and anxieties surrounding genetic testing will be critical for equitable uptake. Future work should consider these patient preferences in designing interventions to improve risk-aligned care.<\/jats:p>","DOI":"10.1007\/s12687-026-00933-4","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:31:59Z","timestamp":1786595519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding patient perspectives on breast cancer risk: a qualitative study to inform genetic testing communication in the primary care setting"],"prefix":"10.1007","volume":"17","author":[{"given":"Jennifer","family":"McGuire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Sterba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1793-6473","authenticated-orcid":false,"given":"Sarah Tucker","family":"Marrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"issue":"4","key":"933_CR14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1067\/j.cpradiol.2020.04.008","volume":"50","author":"N Amornsiripanitch","year":"2021","unstructured":"Amornsiripanitch N, Ameri SM, Goldberg RJ (2021) Primary Care Providers Underutilize Breast Screening MRI for High-Risk Women. Curr Probl Diagn Radiol 50(4):489\u2013494. https:\/\/doi.org\/10.1067\/j.cpradiol.2020.04.008","journal-title":"Curr Probl Diagn Radiol"},{"key":"933_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071390","author":"JW Ankersmid","year":"2024","unstructured":"Ankersmid JW, Engelhardt EG, Lansink Rotgerink FK, The R, Strobbe LJA, Drossaert CHC et al (2024) Evaluation of the implementation of the Dutch breast cancer surveillance decision aid including personalized risk estimates in the SHOUT-BC study: a mixed methods approach. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16071390","journal-title":"Cancers (Basel)"},{"key":"933_CR15","doi-asserted-by":"publisher","first-page":"g2756","DOI":"10.1136\/bmj.g2756","volume":"348","author":"AC Armstrong","year":"2014","unstructured":"Armstrong AC, Evans GD (2014) Management of women at high risk of breast cancer. BMJ 348:g2756. https:\/\/doi.org\/10.1136\/bmj.g2756","journal-title":"BMJ"},{"issue":"Suppl 6","key":"933_CR19","doi-asserted-by":"publisher","first-page":"vi31","DOI":"10.1093\/annonc\/mdp116","volume":"22","author":"J Balmana","year":"2011","unstructured":"Balmana J, Diez O, Rubio IT, Cardoso F, Group EGW (2011) BRCA in breast cancer: ESMO clinical practice guidelines. Ann Oncol 22(Suppl 6):vi31-4. https:\/\/doi.org\/10.1093\/annonc\/mdp116","journal-title":"Ann Oncol"},{"key":"933_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164150","author":"S Bellhouse","year":"2021","unstructured":"Bellhouse S, Hawkes RE, Howell SJ, Gorman L, French DP (2021) Breast cancer risk assessment and primary prevention advice in primary care: a systematic review of provider attitudes and routine behaviours. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13164150","journal-title":"Cancers (Basel)"},{"issue":"5","key":"933_CR8","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1089\/jwh.2018.7463","volume":"29","author":"A Blaes","year":"2020","unstructured":"Blaes A, Vogel RI, Nagler RH, Allen A, Mason S, Teoh D et al (2020) Breast cancer screening practices for high-risk women: a cross-sectional survey of primary care providers. J Womens Health 29(5):686\u201392. https:\/\/doi.org\/10.1089\/jwh.2018.7463","journal-title":"J Womens Health"},{"issue":"3","key":"933_CR31","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1207\/s15324796abm3203_5","volume":"32","author":"DJ Bowen","year":"2006","unstructured":"Bowen DJ, Allen JD, Vu T, Johnson RE, Fryer-Edwards K, Hart A Jr. (2006) Theoretical foundations for interventions designed to promote informed decision making for cancer screening. Ann Behav Med 32(3):202\u201310. https:\/\/doi.org\/10.1207\/s15324796abm3203_5","journal-title":"Ann Behav Med"},{"issue":"1","key":"933_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.amepre.2003.09.012","volume":"26","author":"P Briss","year":"2004","unstructured":"Briss P, Rimer B, Reilley B, Coates RC, Lee NC, Mullen P et al (2004) Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med 26(1):67\u201380. https:\/\/doi.org\/10.1016\/j.amepre.2003.09.012","journal-title":"Am J Prev Med"},{"issue":"2","key":"933_CR39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1080\/14780887.2014.955224","volume":"12","author":"J Brooks","year":"2015","unstructured":"Brooks J, McCluskey S, Turley E, King N (2015) The Utility of Template Analysis in Qualitative Psychology Research. Qual Res Psychol 12(2):202\u2013222. https:\/\/doi.org\/10.1080\/14780887.2014.955224","journal-title":"Qual Res Psychol"},{"issue":"12","key":"933_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002998","volume":"16","author":"T Callender","year":"2019","unstructured":"Callender T, Emberton M, Morris S, Eeles R, Kote-Jarai Z, Pharoah PDP et al (2019) Polygenic risk-tailored screening for prostate cancer: a benefit-harm and cost-effectiveness modelling study. PLoS Med 16(12):e1002998. https:\/\/doi.org\/10.1371\/journal.pmed.1002998","journal-title":"PLoS Med"},{"issue":"2","key":"933_CR61","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.pec.2020.07.017","volume":"104","author":"G Campbell-Salome","year":"2021","unstructured":"Campbell-Salome G, Buchanan AH, Hallquist MLG, Rahm AK, Rocha H, Sturm AC (2021) Uncertainty management for individuals with Lynch Syndrome: Identifying and responding to healthcare barriers. Patient Educ Couns 104(2):403\u2013412. https:\/\/doi.org\/10.1016\/j.pec.2020.07.017","journal-title":"Patient Educ Couns"},{"key":"933_CR32","volume-title":"The Health Belief Model","year":"2008","unstructured":"Champion VSCSF (ed) (2008) editor. The Health Belief Model. Jossey-Bass, San Francisco, CA, Jossey-Bass"},{"issue":"3","key":"933_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/jgc4.70032","volume":"34","author":"E Cilli","year":"2025","unstructured":"Cilli E, Brancati F, Di Giacomo D (2025) Perceived cancer risk and genetic counseling: a biopsychological perspective. J Genet Couns 34(3):e70032. https:\/\/doi.org\/10.1002\/jgc4.70032","journal-title":"J Genet Couns"},{"issue":"1","key":"933_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10549-024-07471-y","volume":"209","author":"CC Conley","year":"2025","unstructured":"Conley CC, Anderson A, Rodriguez JD, Kang H, Taylor EP, Luck C et al (2025) Barriers and facilitators to breast cancer screening among high-risk women: a qualitative study. Breast Cancer Res Treat 209(1):61\u201371. https:\/\/doi.org\/10.1007\/s10549-024-07471-y","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"933_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101307","volume":"27","author":"S Conner","year":"2025","unstructured":"Conner S, Theoryn T, Dusic E, Beers F, Knerr S, Norquist B et al (2025) Primary care provider practices, attitudes, and confidence with hereditary cancer risk assessment and testing: a mixed methods study. Genet Med 27(4):101307. https:\/\/doi.org\/10.1016\/j.gim.2024.101307","journal-title":"Genet Med"},{"issue":"9","key":"933_CR52","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1089\/jwh.2014.4742","volume":"23","author":"J Corbelli","year":"2014","unstructured":"Corbelli J, Borrero S, Bonnema R, McNamara M, Kraemer K, Rubio D et al (2014) Use of the Gail model and breast cancer preventive therapy among three primary care specialties. J Womens Health (Larchmt) 23(9):746\u2013752. https:\/\/doi.org\/10.1089\/jwh.2014.4742","journal-title":"J Womens Health (Larchmt)"},{"key":"933_CR40","first-page":"93","volume-title":"Doing qualitative research","author":"BFM,W Crabtree","year":"1992","unstructured":"Crabtree BFM W (1992) A template approach to text analysis: Developing and using codebooks. Doing qualitative research. Sage Publications, pp 93\u2013109"},{"issue":"1","key":"933_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J (2022) The updated Consolidated Framework for Implementation Research based on user feedback. Implement Sci 17(1):75. https:\/\/doi.org\/10.1186\/s13012-022-01245-0","journal-title":"Implement Sci"},{"issue":"4","key":"933_CR66","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10689-025-00500-9","volume":"24","author":"CL de Jong","year":"2025","unstructured":"de Jong CL, Schijven G, Engelhardt EG, Jager A, Ausems M (2025) Barriers and facilitators for medical oncologists in the further implementation of mainstream genetic testing in breast cancer care in the Netherlands. Fam Cancer 24(4):75. https:\/\/doi.org\/10.1007\/s10689-025-00500-9","journal-title":"Fam Cancer"},{"issue":"1","key":"933_CR23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/jgc4.1189","volume":"29","author":"EW Dekanek","year":"2020","unstructured":"Dekanek EW, Thull DL, Massart M, Grubs RE, Rajkovic A, Mai PL (2020) Knowledge and opinions regarding BRCA1 and BRCA2 genetic testing among primary care physicians. J Genet Couns 29(1):122\u2013130. https:\/\/doi.org\/10.1002\/jgc4.1189","journal-title":"J Genet Couns"},{"key":"933_CR44","doi-asserted-by":"publisher","unstructured":"Esserman LJ, Fiscalini AS, Naeim A, Van\u2019t Veer LJ, Kaster A, Scheuner MT et al (2025) Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial. JAMA. https:\/\/doi.org\/10.1001\/jama.2025.24784","DOI":"10.1001\/jama.2025.24784"},{"issue":"18","key":"933_CR20","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 90(18):1371\u201388. https:\/\/doi.org\/10.1093\/jnci\/90.18.1371","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"933_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1370\/afm.60","volume":"2","author":"R Gramling","year":"2004","unstructured":"Gramling R, Nash J, Siren K, Eaton C, Culpepper L (2004) Family physician self-efficacy with screening for inherited cancer risk. Ann Fam Med 2(2):130\u2013132. https:\/\/doi.org\/10.1370\/afm.60","journal-title":"Ann Fam Med"},{"issue":"3","key":"933_CR24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11606-016-3943-4","volume":"32","author":"JG Hamilton","year":"2017","unstructured":"Hamilton JG, Abdiwahab E, Edwards HM, Fang ML, Jdayani A, Breslau ES (2017) Primary care providers\u2019 cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda. J Gen Intern Med 32(3):315\u2013324. https:\/\/doi.org\/10.1007\/s11606-016-3943-4","journal-title":"J Gen Intern Med"},{"issue":"2","key":"933_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.amepre.2017.10.015","volume":"54","author":"LE Hull","year":"2018","unstructured":"Hull LE, Haas JS, Simon SR (2018) Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation. Am J Prev Med 54(2):221\u2013228. https:\/\/doi.org\/10.1016\/j.amepre.2017.10.015","journal-title":"Am J Prev Med"},{"issue":"16","key":"933_CR67","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1001\/jama.2020.18745","volume":"324","author":"LE Hull","year":"2020","unstructured":"Hull LE, Gold NB, Armstrong KA (2020) Revisiting the Roles of Primary Care Clinicians in Genetic Medicine. JAMA 324(16):1607\u20131608. https:\/\/doi.org\/10.1001\/jama.2020.18745","journal-title":"JAMA"},{"issue":"6","key":"933_CR51","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S1470-2045(23)00156-0","volume":"24","author":"C Huntley","year":"2023","unstructured":"Huntley C, Torr B, Sud A, Rowlands CF, Way R, Snape K et al (2023) Utility of polygenic risk scores in UK cancer screening: a modelling analysis. Lancet Oncol 24(6):658\u201368. https:\/\/doi.org\/10.1016\/S1470-2045(23)00156-0","journal-title":"Lancet Oncol"},{"key":"933_CR29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev.publhealth.19.1.173","volume":"19","author":"BA Israel","year":"1998","unstructured":"Israel BA, Schulz AJ, Parker EA, Becker AB (1998) Review of community-based research: assessing partnership approaches to improve public health. Annu Rev Public Health 19:173\u2013202. https:\/\/doi.org\/10.1146\/annurev.publhealth.19.1.173","journal-title":"Annu Rev Public Health"},{"issue":"1","key":"933_CR65","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/tbm\/ibx042","volume":"8","author":"KA Kaphingst","year":"2018","unstructured":"Kaphingst KA, Ivanovich J, Lyons S, Biesecker B, Dresser R, Elrick A et al (2018) Preferences for learning different types of genome sequencing results among young breast cancer patients: Role of psychological and clinical factors. Transl Behav Med 8(1):71\u201379. https:\/\/doi.org\/10.1093\/tbm\/ibx042","journal-title":"Transl Behav Med"},{"issue":"8","key":"933_CR59","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1038\/s41436-018-0402-0","volume":"21","author":"KA Kaphingst","year":"2019","unstructured":"Kaphingst KA, Peterson E, Zhao J, Gaysynsky A, Elrick A, Hong SJ et al (2019) Cancer communication research in the era of genomics and precision medicine: a scoping review. Genet Med 21(8):1691\u20131698. https:\/\/doi.org\/10.1038\/s41436-018-0402-0","journal-title":"Genet Med"},{"issue":"7","key":"933_CR55","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1158\/1055-9965.EPI-13-1380","volume":"23","author":"CP Kaplan","year":"2014","unstructured":"Kaplan CP, Livaudais-Toman J, Tice JA, Kerlikowske K, Gregorich SE, Perez-Stable EJ et al (2014) A randomized, controlled trial to increase discussion of breast cancer in primary care. Cancer Epidemiol Biomarkers Prev 23(7):1245\u20131253. https:\/\/doi.org\/10.1158\/1055-9965.EPI-13-1380","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"933_CR54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.21037\/mhealth-20-82","volume":"7","author":"CP Kaplan","year":"2021","unstructured":"Kaplan CP, Karliner L, Lee A, Livaudais-Toman J, Tice JA, Ozanne E (2021) Acceptability of an mHealth breast cancer risk-reduction intervention promoting risk assessment, education, and discussion of risk in the primary care setting. Mhealth 7:54. https:\/\/doi.org\/10.21037\/mhealth-20-82","journal-title":"Mhealth"},{"issue":"5","key":"933_CR48","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1053\/j.gastro.2023.02.021","volume":"164","author":"F Kastrinos","year":"2023","unstructured":"Kastrinos F, Kupfer SS, Gupta S (2023) Colorectal Cancer Risk Assessment and Precision Approaches to Screening: Brave New World or Worlds Apart? Gastroenterology 164(5):812\u2013827. https:\/\/doi.org\/10.1053\/j.gastro.2023.02.021","journal-title":"Gastroenterology"},{"key":"933_CR68","doi-asserted-by":"publisher","first-page":"E812","DOI":"10.1001\/amajethics.2018.812","volume":"20","author":"Knapp KBaE","year":"2018","unstructured":"Knapp KBaE (2018) How Should Primary Care Physicians Respond to Direct-to-Consumer Genetic Test Results? AMA J Ethics 20:E812\u2013E818","journal-title":"AMA J Ethics"},{"issue":"23","key":"933_CR16","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ et al (2017) Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. JAMA 317(23):2402\u20132416. https:\/\/doi.org\/10.1001\/jama.2017.7112","journal-title":"JAMA"},{"key":"933_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw302","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, McGuffog L, Barrowdale D, Lee A, Soucy P, Dennis J et al (2017) Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djw302","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"933_CR64","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/jgc4.1688","volume":"32","author":"WL Kuo","year":"2023","unstructured":"Kuo WL, Lin PH, Peng MT, Chu CH, Cho CW (2023) Patients\u2019 attitudes regarding genetic counseling before germline BRCA1\/2 pathogenic variants testing in Taiwan: A single-country, multi-center, patient-reported outcome study. J Genet Couns 32(4):788\u2013797. https:\/\/doi.org\/10.1002\/jgc4.1688","journal-title":"J Genet Couns"},{"issue":"2","key":"933_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.2214\/AJR.19.22205","volume":"214","author":"CS Lee","year":"2020","unstructured":"Lee CS, Monticciolo DL, Moy L (2020) Screening Guidelines Update for Average-Risk and High-Risk Women. AJR Am J Roentgenol 214(2):316\u2013323. https:\/\/doi.org\/10.2214\/AJR.19.22205","journal-title":"AJR Am J Roentgenol"},{"key":"933_CR42","unstructured":"Ltd QIP (2018) NVivo qualitative data analysis software [Computer software]"},{"issue":"11","key":"933_CR49","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1158\/1055-9965.EPI-16-0555","volume":"25","author":"PM Marcus","year":"2016","unstructured":"Marcus PM, Pashayan N, Church TR, Doria-Rose VP, Gould MK, Hubbard RA et al (2016) Population-based precision cancer screening: a symposium on evidence, epidemiology, and next steps. Cancer Epidemiol Biomarkers Prev 25(11):1449\u201355. https:\/\/doi.org\/10.1158\/1055-9965.EPI-16-0555","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"933_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12121943","author":"CZ McCormick","year":"2022","unstructured":"McCormick CZ, Yu KD, Johns A, Campbell-Salome G, Hallquist MLG, Sturm AC et al (2022) Investigating psychological impact after receiving genetic risk results-a survey of participants in a population genomic screening program. J Pers Med. https:\/\/doi.org\/10.3390\/jpm12121943","journal-title":"J Pers Med"},{"issue":"3 Pt A","key":"933_CR18","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jacr.2017.11.034","volume":"15","author":"DL Monticciolo","year":"2018","unstructured":"Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA (2018) Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR. J Am Coll Radiol 15(3 Pt A):408\u2013414. https:\/\/doi.org\/10.1016\/j.jacr.2017.11.034","journal-title":"J Am Coll Radiol"},{"issue":"7","key":"933_CR10","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jama.2019.8430","volume":"322","author":"HD Nelson","year":"2019","unstructured":"Nelson HD, Pappas M, Cantor A, Haney E, Holmes R (2019) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 322(7):666\u201385. https:\/\/doi.org\/10.1001\/jama.2019.8430","journal-title":"JAMA"},{"issue":"9","key":"933_CR9","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1001\/jama.2019.5780","volume":"322","author":"HD Nelson","year":"2019","unstructured":"Nelson HD, Fu R, Zakher B, Pappas M, McDonagh M (2019) Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 322(9):868\u2013886. https:\/\/doi.org\/10.1001\/jama.2019.5780","journal-title":"JAMA"},{"issue":"1","key":"933_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/160940691773384","volume":"16","author":"LSNJ Nowell","year":"2017","unstructured":"Nowell LSNJ, WD (2017) Moules NJ Thematic analysis: Striving to meet the trustworthiness criteria. Int J Qualitative Methods 16(1):1\u201313. https:\/\/doi.org\/10.1177\/160940691773384","journal-title":"Int J Qualitative Methods"},{"issue":"3","key":"933_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2217\/pme.13.20","volume":"10","author":"LA Orlando","year":"2013","unstructured":"Orlando LA, Henrich VC, Hauser ER, Wilson C, Ginsburg GS, Genomedical C (2013) The genomic medicine model: an integrated approach to implementation of family health history in primary care. Per Med 10(3):295\u2013306. https:\/\/doi.org\/10.2217\/pme.13.20","journal-title":"Per Med"},{"key":"933_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17071056","author":"P Padrik","year":"2025","unstructured":"Padrik P, Tonisson N, Hovda T, Sahlberg KK, Hovig E, Costa L et al (2025) Guidance for the clinical use of the breast cancer polygenic risk scores. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers17071056","journal-title":"Cancers (Basel)"},{"issue":"11","key":"933_CR45","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41571-020-0388-9","volume":"17","author":"N Pashayan","year":"2020","unstructured":"Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, French D et al (2020) Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol 17(11):687\u2013705. https:\/\/doi.org\/10.1038\/s41571-020-0388-9","journal-title":"Nat Rev Clin Oncol"},{"key":"933_CR57","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ypmed.2016.09.034","volume":"93","author":"EB Peterson","year":"2016","unstructured":"Peterson EB, Ostroff JS, DuHamel KN, D\u2019Agostino TA, Hernandez M, Canzona MR et al (2016) Impact of provider-patient communication on cancer screening adherence: A systematic review. Prev Med 93:96\u2013105. https:\/\/doi.org\/10.1016\/j.ypmed.2016.09.034","journal-title":"Prev Med"},{"issue":"1","key":"933_CR56","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/tbm\/ibx063","volume":"8","author":"EB Peterson","year":"2018","unstructured":"Peterson EB, Chou WS, Gaysynsky A, Krakow M, Elrick A, Khoury MJ et al (2018) Communication of cancer-related genetic and genomic information: A landscape analysis of reviews. Transl Behav Med 8(1):59\u201370. https:\/\/doi.org\/10.1093\/tbm\/ibx063","journal-title":"Transl Behav Med"},{"issue":"3","key":"933_CR38","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1037\/0022-006X.51.3.390","volume":"51","author":"JO Prochaska","year":"1983","unstructured":"Prochaska JO, DiClemente CC (1983) Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 51(3):390\u2013395","journal-title":"J Consult Clin Psychol"},{"issue":"5 Suppl","key":"933_CR33","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/cncr.20512","volume":"101","author":"BK Rimer","year":"2004","unstructured":"Rimer BK, Briss PA, Zeller PK, Chan EC, Woolf SH (2004) Informed decision making: what is its role in cancer screening? Cancer 101(5 Suppl):1214\u20131228. https:\/\/doi.org\/10.1002\/cncr.20512","journal-title":"Cancer"},{"key":"933_CR46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.breast.2023.01.003","volume":"67","author":"E Roberts","year":"2023","unstructured":"Roberts E, Howell S, Evans DG (2023) Polygenic risk scores and breast cancer risk prediction. Breast 67:71\u201377 https:\/\/doi.org\/10.1016\/j.breast.2023.01.003","journal-title":"Breast"},{"issue":"2","key":"933_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","volume":"57","author":"D Saslow","year":"2007","unstructured":"Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75\u201389. https:\/\/doi.org\/10.3322\/canjclin.57.2.75","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"933_CR43","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","volume":"52","author":"B Saunders","year":"2018","unstructured":"Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B et al (2018) Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant 52(4):1893\u20131907. https:\/\/doi.org\/10.1007\/s11135-017-0574-8","journal-title":"Qual Quant"},{"issue":"5","key":"933_CR37","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3122\/jabfm.2021.05.210149","volume":"34","author":"N Shungu","year":"2021","unstructured":"Shungu N, Sterba KR (2021) Barriers and facilitators to informed decision-making about prostate cancer screening among Black men. J Am Board Fam Med 34(5):925\u201336. https:\/\/doi.org\/10.3122\/jabfm.2021.05.210149","journal-title":"J Am Board Fam Med"},{"issue":"3","key":"933_CR2","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jacr.2022.12.019","volume":"20","author":"LB Spalluto","year":"2023","unstructured":"Spalluto LB, Bonnet K, Sonubi C, Ernst LL, Wahab R, Reid SA et al (2023) Barriers to Implementation of Breast Cancer Risk Assessment: The Health Care Team Perspective. J Am Coll Radiol 20(3):342\u2013351. https:\/\/doi.org\/10.1016\/j.jacr.2022.12.019","journal-title":"J Am Coll Radiol"},{"issue":"2","key":"933_CR26","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1016\/S2468-2667(24)00278-0","volume":"10","author":"NQP Tan","year":"2025","unstructured":"Tan NQP, Nargund RS, Douglas EE, Lopez-Olivo MA, Resong PJ, Ishizawa S et al (2025) Acceptability and perceptions of personalised risk-based cancer screening among health-care professionals and the general public: a systematic review and meta-analysis. Lancet Public Health 10(2):e85\u2013e96. https:\/\/doi.org\/10.1016\/S2468-2667(24)00278-0","journal-title":"Lancet Public Health"},{"issue":"3","key":"933_CR27","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/hex.13739","volume":"26","author":"LC Taylor","year":"2023","unstructured":"Taylor LC, Hutchinson A, Law K, Shah V, Usher-Smith JA, Dennison RA (2023) Acceptability of risk stratification within population-based cancer screening from the perspective of the general public: A mixed-methods systematic review. Health Expect 26(3):989\u20131008 https:\/\/doi.org\/10.1111\/hex.13739","journal-title":"Health Expect"},{"issue":"4","key":"933_CR60","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/pon.5840","volume":"31","author":"G Tiernan","year":"2022","unstructured":"Tiernan G, Freeman V, Morrow A, Hogden E, Canfell K, Kang YJ et al (2022) What would i do? Perspectives on the factors underlying Lynch syndrome genetic testing and results sharing decisions for high-risk colorectal cancer patients. Psychooncology 31(4):587\u201396. https:\/\/doi.org\/10.1002\/pon.5840","journal-title":"Psychooncology"},{"issue":"6","key":"933_CR34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 19(6):349\u201357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042","journal-title":"Int J Qual Health Care"},{"issue":"9","key":"933_CR28","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41416-023-02145-w","volume":"128","author":"JA Usher-Smith","year":"2023","unstructured":"Usher-Smith JA, Hindmarch S, French DP, Tischkowitz M, Moorthie S, Walter FM et al (2023) Proactive breast cancer risk assessment in primary care: a review based on the principles of screening. Br J Cancer 128(9):1636\u20131646. https:\/\/doi.org\/10.1038\/s41416-023-02145-w","journal-title":"Br J Cancer"},{"issue":"7","key":"933_CR3","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1001\/jama.2019.17850","volume":"322","author":"USPTF","year":"2019","unstructured":"USPSTF, Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M et al (2019) Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 322(7):652\u2013665. https:\/\/doi.org\/10.1001\/jama.2019.17850","journal-title":"JAMA"},{"key":"933_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041124","author":"LS Velentzis","year":"2023","unstructured":"Velentzis LS, Freeman V, Campbell D, Hughes S, Luo Q, Steinberg J et al (2023) Breast cancer risk assessment tools for stratifying women into risk groups: a systematic review. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15041124","journal-title":"Cancers (Basel)"},{"issue":"5","key":"933_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s13058-014-0451-5","volume":"16","author":"J Warwick","year":"2014","unstructured":"Warwick J, Birke H, Stone J, Warren RM, Pinney E, Brentnall AR et al (2014) Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I. Breast Cancer Res 16(5):451. https:\/\/doi.org\/10.1186\/s13058-014-0451-5","journal-title":"Breast Cancer Res"}],"container-title":["Journal of Community Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-026-00933-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12687-026-00933-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-026-00933-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:02:41Z","timestamp":1787947361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12687-026-00933-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":65,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["933"],"URL":"https:\/\/doi.org\/10.1007\/s12687-026-00933-4","relation":{},"ISSN":["1868-6001"],"issn-type":[{"value":"1868-6001","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"10 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Kevin Hughes has received honoraria and consulting fees from Targeted Medical Education\/Aptitude Health, LabCorp, LetsGetChecked, Hologic, Volpara, and AstraZeneca. The additional authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"<b>Competing interest<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"97"}}